Fitzpatrick Lab awarded Dana Foundation David Mahoney Neuroimaging grant

The Fitzpatrick lab is using cryo-EM of postmortem tissue from people with neurodegenerative diseases to differentiate each disease’s molecular signature leading to improved diagnoses of patients through Positron Emission Tomography (PET) imaging by developing PET tracers that bind to the molecules involved in each disease. PET could then be used to differentiate, diagnose, and monitor progression of each neurodegenerative disease.